Boryung Corporation (KRX:003850)

South Korea flag South Korea · Delayed Price · Currency is KRW
9,420.00
+10.00 (0.11%)
Mar 18, 2026, 3:30 PM KST
Market Cap795.81B -8.1%
Revenue (ttm)1.03T +3.8%
Net Income56.45B -9.0%
EPS688.80 -26.7%
Shares Out84.48M
PE Ratio13.68
Forward PE21.03
Dividend100.00 (1.06%)
Ex-Dividend DateDec 29, 2025
Volume104,350
Average Volume249,383
Open9,440.00
Previous Close9,410.00
Day's Range9,350.00 - 9,480.00
52-Week Range7,680.00 - 10,800.00
Beta0.30
RSI48.63
Earnings DateMay 15, 2026

About Boryung

Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, and diabetes drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1957
Employees 1,335
Stock Exchange Korea Stock Exchange
Ticker Symbol 003850
Full Company Profile

Financial Performance

In 2024, Boryung's revenue was 1.02 trillion, an increase of 18.32% compared to the previous year's 859.63 billion. Earnings were 69.63 billion, an increase of 73.20%.

Financial Statements